It can also be a temporary issue or something consistent
Other GLP-1 medications, such as Ozempic (semaglutide) and Mounjaro (tirzepatide), are approved for diabetes but used off-label to help patients lose weight
People who are overweight tend to have higher intracranial pressure, and the relationship between obesity and migraine frequency is well established
However, the SUSTAIN six trial evaluated semaglutide, a GLP-1 analog, in patients with type 2 diabetes and high cardiovascular risk and discovered that semaglutide was associated with a higher incidence of diabetic retinopathy complications compared to placebo, with a hazard ratio (HR) of 1.76, particularly in patients with pre-existing DR ( This seemingly controversial impact of GLP-1RAs on DR may be because most trials focused on microvascular and cardiovascular outcomes rather than DR
Strong outcomes for patients managing both diabetes and obesity
Your body produces it on its own and tucks it away in muscle tissue, where it serves as a ready fuel source for high-intensity efforts, and topping up with one of the best creatine supplements can impact your performance